ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)
$303.59 -7.35 (-2.3638%)
Analysed ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) News Sources
Truist Lowers PT on Alnylam Pharmaceuticals (ALNY) to $505 From $515
20-04-2026
yahoo.com
A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple
17-04-2026
yahoo.com
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
16-04-2026
yahoo.com
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
13-04-2026
yahoo.com
Is Alnylam Pharmaceuticals (ALNY) The Best Growth Stock?
12-04-2026
yahoo.com
Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025
09-04-2026
yahoo.com
Alnylam Cardiovascular Data Highlights Potential Upside In ATTR-CM And Hypertension
08-04-2026
yahoo.com
Is the Options Market Predicting a Spike in Alnylam Pharmaceuticals Stock?
07-04-2026
yahoo.com
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06-04-2026
yahoo.com
Alnylam Pharmaceuticals (ALNY) Presents Vutrisiran ATTR-CM Data at ACC.26
03-04-2026
yahoo.com
What is the current price of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)?
The current price of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) is $303.59.
ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) since the previous trading day is $-7.35.
ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) since the previous trading day is -2.3638%.
What is the most recent average sentiment score for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)?
The most recent average sentiment score for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)?
The most recent sentiment for ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ) is .
SEC-8K** Filing Available For ALNYLAM PHARMACEUTICALS INC (ALNY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.